Who owns Elicio Therapeutics Inc Com?
- Ticker: ELTX
- CUSIP Number: 28657f103
Tip: Access positions for across all investors
Analyze quarterly positions in Elicio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Elicio Therapeutics stock
Who bought or sold Elicio Therapeutics Inc Com this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 246k | $1.2M | 0% | Dec 2024 |
|
Geode Capital Management | 71k | $347k | -1% | Dec 2024 |
|
CM Management | 40k | $204k | -20% | Dec 2024 |
|
Northern Trust | 31k | $157k | 0% | Dec 2024 |
|
State Street Corporation | 22k | $107k | 0% | Dec 2024 |
|
BlackRock | 20k | $101k | 1% | Dec 2024 |
|
Meyer Handelman | 14k | $71k | 0% | Dec 2024 |
|
Atlantic Trust | 7.0k | $43k | 0% | Dec 2024 |
|
Steward Partners Investment Advisory | 1.6k | $7.9k | 0% | Dec 2024 |
|
Bank of America Corporation | 1.2k | $6.1k | -3% | Dec 2024 |
|
National Bank Of Canada /fi/ | 800.00 | $4.0k | -47% | Sep 2024 |
|
Tower Research Capital | 611.00 | $3.1k | -36% | Dec 2024 |
|
Citigroup | 374.00 | $1.8k | 0% | Dec 2024 |
|
Morgan Stanley | 230.00 | $1.2k | -4% | Dec 2024 |
|
SBI Securities | 83.00 | $423.001200 | 100% | Dec 2024 |
|
Bnp Paribas Arbitrage, Snc | 65.00 | $332.000500 | 100% | Dec 2024 |
|
Jpmorgan Chase & Co | 18.00 | $88.000200 | 0% | Dec 2024 |
|
UBS Group | 17.00 | $86.999200 | -98% | Dec 2024 |
|
Who sold out of Elicio Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Citadel Advisors | Sep 2024 | 13k | $65k |
Bridgeway Capital Management | Sep 2024 | 13k | $63k |